Tellimus 2 € eest

Alates 2 eurost kindlustatud

Financial Data API

Terminal Financial Data API

Royalty Pharma Aktie News & Pressemeldungen

Royalty Pharma Eulerpool Uudised

6.2.2024, 18:26:31

Novartis setzt auf Krebsmedikament Pelabresib und erwirbt Morphosys für 2,7 Milliarden Euro

6.2.2024, 12:48:27

Novartis erwirbt Biotech-Perle Morphosys für 2,7 Milliarden Euro

1

1

Royalty Pharma aktsia uudised

Royalty Pharma jälgivad paljud ajakirjanikud ja investorid üle kogu maailma. Kõige värskemad Royalty Pharma uudised paneme siia kokku.

24. detsember ·
Yahoo
Royalty Pharma plc (NASDAQ:RPRX) is favoured by institutional owners who hold 72% of the company
24. detsember ·
Yahoo
Jim Cramer Calls Royalty Pharma (RPRX) ‘Disappointing’ But Recommends Holding – ‘I Want You To Stick With It’
19. detsember ·
SeekingAlpha
PeptiDream: Opulent Dream Now A Reality
10. detsember ·
SeekingAlpha
Tracking Ole Andreas Halvorsen's Viking Global Portfolio - Q3 2024 Update
27. november ·
Yahoo
Royalty Pharma to Present at Upcoming Investor Conferences
27. november ·
Yahoo
Why Royalty Pharma (RPRX) is the Cheapest Stock to Buy on Robinhood?
25. november ·
SeekingAlpha
5 Reasons Bristol-Myers Squibb Looks Good Now (Rating Upgrade)
16. november ·
SeekingAlpha
Undercovered Dozen: Aurora Cannabis, FREYR Battery, Royalty Pharma, Talos Energy +
14. november ·
Yahoo
Royalty Pharma Announces Inaugural Prize for Impact in Healthcare
13. november ·
Yahoo
Royalty Pharma's (NASDAQ:RPRX) Profits May Not Reveal Underlying Issues

1

2

1

2

Royalty Pharma aktsia pressiteated

Royalty Pharma avaldab ettevõtte veebisaidil regulaarselt investoreid huvitavaid teateid.

Tee oma elu parimad investeeringud

Alates 2 eurost kindlustatud